ON

Osamu Nureki

TT The University Of Tokyo: 12 patents #44 of 2,633Top 2%
TI The Broad Institute: 6 patents #77 of 760Top 15%
MIT: 6 patents #748 of 9,367Top 8%
Harvard University: 5 patents #395 of 3,600Top 15%
SC Shionogi & Co.: 2 patents #396 of 1,054Top 40%
MT Modalis Therapeutics: 2 patents #4 of 13Top 35%
TU Tohoku University: 2 patents #330 of 1,680Top 20%
Overall (All Time): #395,356 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
12258595 Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems Silvana Konermann, Alexandro Trevino, Mark Brigham, Fei Ran, Patrick Hsu +4 more 2025-03-25
12168789 Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation Feng Zhang, Winston X. Yan, Kaijie Zheng, Le Cong, Hiroshi Nishimasu +2 more 2024-12-17
12152259 Modified CAS9 protein, and use thereof Hiroshi Nishimasu, Hisato HIRANO, Shohei KAJIMOTO, Tetsuya YAMAGATA, Yuanbo QIN +2 more 2024-11-26
11702645 Polynucleotide encoding modified CAS9 protein Hiroshi Nishimasu, Hisato HIRANO 2023-07-18
11597919 Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems Silvana Konermann, Alexandro Trevino, Mark Brigham, Fei Ran, Patrick Hsu +4 more 2023-03-07
11578312 Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation Feng Zhang, Winston X. Yan, Kaijie Zheng, Le Cong, Hiroshi Nishimasu +2 more 2023-02-14
11530396 Modified CAS9 protein, and use thereof Hiroshi Nishimasu, Hisato HIRANO, Shohei KAJIMOTO, Tetsuya YAMAGATA, Yuanbo QIN +2 more 2022-12-20
11371030 Modified Cas9 protein and use thereof Hiroshi Nishimasu, Hisato HIRANO 2022-06-28
11155795 CRISPR-Cas systems, crystal structure and uses thereof Feng Zhang, Hiroshi Nishimasu, Ryuichiro ISHITANI 2021-10-26
10550372 Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems Silvana Konermann, Alexandro Trevino, Mark Brigham, Fei Ran, Patrick Hsu +4 more 2020-02-04
10189843 Fused pyrazole derivative having autotaxin inhibitory activity Tetsuo Nagano, Takayoshi Okabe, Hirotatsu Kojima, Mitsuyasu KAWAGUCHI, Ryuichiro ISHITANI +8 more 2019-01-29
10183949 Pyrimidinone derivative having autotaxin-inhibitory activity Tetsuo Nagano, Takayoshi Okabe, Hirotatsu Kojima, Mitsuyasu KAWAGUCHI, Ryuichiro ISHITANI +8 more 2019-01-22